References
- . Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918–1920 “Spanish” influenza pandemic. Bull Hist Med. 2002;76(1):105–115
- . Baden LR, Drazen JM, Kritek PA,. H1N1 influenza A disease—Information for health professionals. N Engl J Med. 2009;360(25):2666–2667
- . Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection—United States, April–August 2009. MMWR Morb Mortal Wkly Rep. 2009;58(34):941–947
- . Intensive-care patients with severe novel influenza A (H1N1) virus infection—Michigan, June 2009. MMWR Morb Mortal Wkly Rep. 2009;58(27):749–752
- . Fitzgerald DA. Human swine influenza A [H1N1]: practical advice for clinicians early in the pandemic. Paediatr Respir Rev. 2009;10(3):154–158
- . Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis—North Carolina, 2009. MMWR Morb Mortal Wkly Rep. 2009;58(35):969–972
- . Hurt AC, Alexander R, Hibbert J,. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol. 2007;39(2):132–135
- . Ginocchio CC, Zhang F, Manji R,. Evaluation of multiple test methods for the detection of the novel 2009 influenza A H1N1 during the New York City outbreak. J Clin Virol. 2009;45(3):191–195
- . Gooskens J, Jonges M, Claas EC,. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J Infect Dis. 2009;199(10):1435–1441
- . Block SL, Yogev R, Hayden FG,. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age. Vaccine. 2008;26(38):4940–4946
- . Lynch JP 3rd, Walsh EE. Influenza: evolving strategies in treatment and prevention. Semin Respir Crit Care Med. 2007(2):144–158
- . Update: influenza activity—United States, August 30–October 31, 2009. MMWR Morb Mortal Wkly Rep. 2009;58(44):1236–1241